Interestingly, CCNA2 is found significantly positively correlated with immune therapy response in BLCA, BRCA, KIRC, LGG, LUAD, PRAD, and THCA while negatively correlated with ACC, GBM, and TGCT. The gene discussed is CCNA2; the disease is bladder transitional cell carcinoma.